TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33846086

Group type: EXPERIMENTAL
Intervention: Saphir RX
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Air Optix Aqua for Astigmatism
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Biofinity Toric
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Acuvue Vita for Astigmatism
Number of subjects: 95
Study: 36215267

Group type: EXPERIMENTAL
Intervention: TFV/LNG IVR (used continuously or cyclically)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: TFV/LNG IVR
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 47
Study: 34763080

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (CCT) using BrainHQ
Number of subjects: 256

Group type: COMPARATOR
Intervention: Computerized crossword puzzles (active control)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 256
Study: 34052943

Group type: EXPERIMENTAL
Intervention: Conscious sedation (CS) with propofol and sufentanil (0.1 mg/kg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Deep sedation (DS) with propofol and sufentanil (0.05 mg/kg)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Conscious sedation (CS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Deep sedation (DS)
Number of subjects: 115
Study: 32026447

Group type: EXPERIMENTAL
Intervention: White matter lesions (WML) grade 1-4 at dCT
Number of subjects: 635

Group type: COMPARATOR
Intervention: Primary HE endpoint (> 33% or > 6 mL ICH volume increase)
Number of subjects: 635

Group type: COMPARATOR
Intervention: Secondary HE outcomes (absolute ICH expansion, > 10.4 mL total clot volume increase)
Number of subjects: 635
Study: 35934188

Group type: EXPERIMENTAL
Intervention: Mobile-Bearing TKA
Number of subjects: 98

Group type: COMPARATOR
Intervention: Fixed-Bearing TKA
Number of subjects: 98
Study: 33422047

Group type: EXPERIMENTAL
Intervention: Interactive text message
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Postcard reminder
Number of subjects: 286

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Phone-based Motivational Interviewing (MI)
Number of subjects: 286
Study: 32966475

Group type: EXPERIMENTAL
Intervention: Flaxseed meal (FM) supplemented biscuits
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control biscuits
Number of subjects: 53
Study: 616391466

Group type: EXPERIMENTAL
Intervention: Biperiden
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute Tryptophan Depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of biperiden and ATD
Number of subjects: 0
Study: 35094138

Group type: EXPERIMENTAL
Intervention: Automated machine learning-based prognostic algorithm (previous exposure in a pragmatic randomized trial)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Automated machine learning-based prognostic algorithm
Number of subjects: 29
Study: 32831908

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3 + a calcinated magnesium placebo (n = 16)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100 μg of Vitamin K2 + a calcinated magnesium placebo (n = 12)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3 + 100 μg vitamin K2 (n = 12)
Number of subjects: 40
Study: 36285519

Group type: EXPERIMENTAL
Intervention: Dalpiciclib 100 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dalpiciclib 125 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dalpiciclib 150 mg
Number of subjects: 36
Study: 34161466

Group type: EXPERIMENTAL
Intervention: Percutaneous mitral balloon valvuloplasty
Number of subjects: 527

Group type: COMPARATOR
Intervention: Mitral valve replacement
Number of subjects: 527
Study: 32744385

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 8
Study: 34878502

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 9718

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9718
Study: 33710347

Group type: EXPERIMENTAL
Intervention: Treatment as usual with additional differential treatment component
Number of subjects: 219
Study: 33066869

Group type: EXPERIMENTAL
Intervention: Methylcobalamin (500 mcg/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/day) + Methylcobalamin (500 mcg/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard oral anti-diabetic drugs
Number of subjects: 80
Study: 35533490

Group type: EXPERIMENTAL
Intervention: Cold therapy applied before deep breathing and coughing exercises
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no cold therapy)
Number of subjects: 70
Study: 32991994

Group type: EXPERIMENTAL
Intervention: Seamless designs in diagnostic research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accuracy studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized diagnostic studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change-in-management studies
Number of subjects: 0
Study: 32479544

Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme with CBT, healthy diet, and physical therapy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme without SMS
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme with SMS
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Lifestyle (LS) programme
Number of subjects: 155

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 155
Study: 36371903

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 440
Study: 32448934

Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 209

Group type: COMPARATOR
Intervention: Nursing students
Number of subjects: 209
Study: 33109859

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 μg/kg/h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dexmedetomidine 0.5 μg/kg/h
Number of subjects: 24
Study: 36362704

Group type: EXPERIMENTAL
Intervention: Proactive therapy (intermittent use of a very strong topical corticosteroid for 4 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Rank-down therapy (daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Rank-down therapy
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Proactive therapy
Number of subjects: 49
Study: 33011188

Group type: EXPERIMENTAL
Intervention: Explicit learning of different types of linguistic information of artificial words (phonological, phonological + semantic, or phonological + orthographic information)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no explicit learning of words)
Number of subjects: 0
Study: 34788453

Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: COVID-19 impact
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: COVID-19 related stress
Number of subjects: 196
Study: 33388052

Group type: EXPERIMENTAL
Intervention: Understanding of informed consent for randomized clinical trials in emergency obstetric and newborn care.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Perceptions of the necessity of research in emergency obstetric and newborn care.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Influence of emergency contexts on understanding research information.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Concerns regarding risks to unborn babies or newborns.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Influence of solidarity on decision-making.
Number of subjects: 18
Study: 33314790

Group type: EXPERIMENTAL
Intervention: Ozanimod and its major active metabolites (CC112273 and CC1084037)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33017662

Group type: EXPERIMENTAL
Intervention: Quizartinib
Number of subjects: 367

Group type: COMPARATOR
Intervention: Salvage chemotherapy
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Transplanted patients (both arms)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Patients with last recorded response of CRc before allo-HSCT (both arms)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Quizartinib (post-allo-HSCT)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Salvage chemotherapy (post-allo-HSCT)
Number of subjects: 367
Study: 33136142

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a-tDCS)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (c-tDCS)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 2
Study: 32475457

Group type: EXPERIMENTAL
Intervention: Ca‐deficient diet (0.35% Ca + 0.45% NPP)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: P‐deficient diet (1.00% Ca + 0.23% NPP)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Ca- and P-deficient diet (0.35% Ca + 0.23% NPP)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Ca- and P-adequate diet (1.00% Ca + 0.45% NPP)
Number of subjects: 504
Study: 34197135

Group type: EXPERIMENTAL
Intervention: Cannabis risk reduction intervention
Number of subjects: 225
Study: 32950254

Group type: EXPERIMENTAL
Intervention: TRIOS 3 (TR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CEREC Omnicam (OC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Complete-crown scan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both scanners
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Complete-arch scans
Number of subjects: 20
Study: 36045468

Group type: EXPERIMENTAL
Intervention: Essential oils mouthwash
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Combination of essential oils and 0.12% chlorhexidine mouthwash
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (0.8%) mouthwash
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Prebiotic mouthwash
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 180
Study: 35399802

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 140

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 140
Study: 34018671

Group type: EXPERIMENTAL
Intervention: Gracey curettes-Hu-Friedy®
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Piezoelectric ultrasonic (Satelec®)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Piezosurgery ultrasonic (Mectron®)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Diamond burs 40µm (Intensiv Perioset®)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 17
Study: 32585686

Group type: EXPERIMENTAL
Intervention: Gonadotropins
Number of subjects: 666

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 666
Study: 35483297

Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AurPrs)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham AurPrs treatment
Number of subjects: 56
Study: 33875811

Group type: EXPERIMENTAL
Intervention: Stoss therapy (single high-dose oral vitamin D therapy) plus weekly/daily supplementation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard of care (per US Endocrine Society guidelines)
Number of subjects: 48
Study: 35871441

Group type: EXPERIMENTAL
Intervention: Endoscopic stapedotomy (n = 44)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Microscopic stapedotomy (n = 44)
Number of subjects: 88
Study: 33517725

Group type: EXPERIMENTAL
Intervention: Cast immobilization
Number of subjects: 100

Group type: COMPARATOR
Intervention: Volar locking plate operation
Number of subjects: 100
Study: 32663945

Group type: EXPERIMENTAL
Intervention: Deceptive active placebo via intranasal application with expectancy-enhancing instructions
Number of subjects: 91

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 91
Study: 32308130

Group type: EXPERIMENTAL
Intervention: VIPP‐SD intervention (Nintervention = 40)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (Ncontrol = 28)
Number of subjects: 68
Study: 32303737

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TAC) injections (10 mg/ml), with up to three injections administered over 12 weeks (initial injection, followed by two additional injections 6 weeks apart).
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group receiving usual care for hypertrophic scars.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TAC injections (10 mg/ml).
Number of subjects: 50
Study: 33529794

Group type: EXPERIMENTAL
Intervention: Trabecular bypass shunts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser-based cyclodestruction procedures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trabeculectomies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional glaucoma surgeries
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician payment data
Number of subjects: 0
Study: 35246380

Group type: EXPERIMENTAL
Intervention: Lean intervention (relocating the printer to the front desk)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lean intervention (adding another parallel working station)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lean intervention (documenting in plain typing)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lean intervention (rerouting delayed patients to the next available physician)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lean intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33461484

Group type: EXPERIMENTAL
Intervention: Electromagnetic guidance ultrasound system
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional ultrasound guidance
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study: 35733201

Group type: EXPERIMENTAL
Intervention: CANreduce 2.0 with psychological support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CANreduce 2.0 without psychological support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 33256737

Group type: EXPERIMENTAL
Intervention: Non-social condition
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Social condition
Number of subjects: 225
Study: 33389304

Group type: EXPERIMENTAL
Intervention: Secret Agent Society (SAS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Caregiver-supported cognitive skills training game (CIA)
Number of subjects: 70
Study: 33210634

Group type: EXPERIMENTAL
Intervention: Social health insurance scheme awareness
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Social health insurance scheme importance
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Source of information
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Benefits of health insurance
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Future renewal of health insurance
Number of subjects: 385
Study: 34877694

Group type: EXPERIMENTAL
Intervention: Continuous, cycling stimulation of CM-DBS for 3 months (blinded phase)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All patients (both groups)
Number of subjects: 20
Study: 33298143

Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg orally twice a day for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benzathine penicillin G 2.4 M IU intramuscularly once
Number of subjects: 0
Study: 33547756

Group type: EXPERIMENTAL
Intervention: Hospital avoidance program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32389377

Group type: EXPERIMENTAL
Intervention: Fully guided protocol with cylindrical guiding holes (12 implants)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fully guided protocol with C-shaped guiding holes (12 implants)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Partially guided protocol with cylindrical guiding holes (12 implants)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Partially guided protocol with C-shaped guiding holes (12 implants)
Number of subjects: 12
Study: 33176084

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 3232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3232
Study: 34059092

Group type: EXPERIMENTAL
Intervention: 4-channel NMES
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2-channel NMES
Number of subjects: 26

Group type: COMPARATOR
Intervention: Comparison of 4-channel NMES vs 2-channel NMES
Number of subjects: 26
Study: 32883216

Group type: EXPERIMENTAL
Intervention: Selection Model (SM)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Pattern-Mixture Model (PMM)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Shared-Parameters Model (SPM)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Linear Mixed Models (LMM)
Number of subjects: 267
Study: 33211352

Group type: EXPERIMENTAL
Intervention: Topical 0.5% timolol maleate (TM) applied to one cheek
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal saline applied to the contralateral cheek (control)
Number of subjects: 25
Study: 32678485

Group type: EXPERIMENTAL
Intervention: ENTRAMI technique (surgical release)
Number of subjects: 15
Study: 35268024

Group type: EXPERIMENTAL
Intervention: Gummy L. plantarum Dad‐13 (108‐9 CFU/3 g) for 50 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 50 days
Number of subjects: 30
Study: 33040613

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4742

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4742
Study: 32798463

Group type: EXPERIMENTAL
Intervention: Immediate stenting
Number of subjects: 305

Group type: COMPARATOR
Intervention: Delayed stenting (after 24 to 48 hours with antithrombin therapy)
Number of subjects: 305
Study: 36280151

Group type: EXPERIMENTAL
Intervention: Accelerated hypofractionated radiotherapy (1.8 Gy daily to PTV with a 0.6 Gy boost to GTV, total 45 Gy to PTV and 60 Gy to GTV in 25 fractions over 5 weeks)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (2 Gy daily to PTV, total 44 Gy to PTV and 60 Gy to GTV in 30 fractions over 6 weeks)
Number of subjects: 266
Study: 32779034

Group type: EXPERIMENTAL
Intervention: Docetaxel plus S-1 (DS)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cisplatin plus S-1 (CS)
Number of subjects: 61
Study: 35596830

Group type: EXPERIMENTAL
Intervention: Pathways early autism intervention for children under 3 years
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pathways early autism intervention for children over 3 years
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pathways early autism intervention
Number of subjects: 67

Group type: COMPARATOR
Intervention: Services-as-usual
Number of subjects: 67
Study: 34407493

Group type: EXPERIMENTAL
Intervention: Online hazard perception training course
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Parent-supervisors observing the course
Number of subjects: 26

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 26
Study: 32162822

Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 412

Group type: COMPARATOR
Intervention: Physician's choice of chemotherapy (PCT)
Number of subjects: 412
Study: 35380740

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5mg BID
Number of subjects: 1947

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10mg BID
Number of subjects: 1947
Study: 33947729

Group type: EXPERIMENTAL
Intervention: Episodic adalimumab monotherapy (24 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Step-up care starting with corticosteroids
Number of subjects: 0
Study: 32988625

Group type: EXPERIMENTAL
Intervention: Palonosetron-dexamethasone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Ondansetron-dexamethasone
Number of subjects: 64
Study: 35562806

Group type: EXPERIMENTAL
Intervention: 3D print
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Head-mounted virtual reality headset
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Demonstration on a regular computer screen
Number of subjects: 25

Group type: COMPARATOR
Intervention: Viewing the CT scan on a computer screen (gold standard)
Number of subjects: 25
Study: 32423429

Group type: EXPERIMENTAL
Intervention: Onkyeong-tang (OKT), 3 g orally three times per day for 8 weeks
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo, 3 g orally three times per day for 8 weeks
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Onkyeong-tang (OKT)
Number of subjects: 112
Study: 36495245

Group type: EXPERIMENTAL
Intervention: Combined medical & mechanical method (trans-cervical foley catheter inflated with 60ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical method alone (mifepristone 200mg, followed by vaginal misoprostol 400μg every 4h)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined medical & mechanical method
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical method alone
Number of subjects: 60
Study: 32826639

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise with 60% BSA coverage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise with 40% BSA coverage
Number of subjects: 10

Group type: COMPARATOR
Intervention: Moderate-intensity exercise with 0% BSA coverage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (0%, 20%, 40%, 60% BSA coverage)
Number of subjects: 10
Study: 32756091

Group type: EXPERIMENTAL
Intervention: Liuwei Dihuang pills (LDP)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 34820771

Group type: EXPERIMENTAL
Intervention: 10 mg/day rosuvastatin for 6 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care for 6 months
Number of subjects: 35
Study: 32644844

Group type: EXPERIMENTAL
Intervention: 14-lncRNA signature
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Nomogram incorporating lncRNA signature and clinical factors
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: lncRNA signature
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: GSEA analysis
Number of subjects: 341
Study: 35954698

Group type: EXPERIMENTAL
Intervention: Isometric training (Handgrip Jamar®)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ventilatory muscle training (PowerBreathe®)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (conventional respiratory and motor physiotherapy)
Number of subjects: 15